ARCHIVES

Congress Passes Unprecedented 15% Increase For NIH On Last Day Of Session

This article is from The Cancer Letter archive.

Vol. 24 No. 40 | October 23, 1998

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group Clinical Trials Approved

November 27, 2009

SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.

April 22, 2005

Cause Of Allergic Reaction To Cetuximab Found

March 28, 2008

Senate Approves FY08 Labor-HHS Appropriations.

October 26, 2007

Univ. Officials Propose Conflict Of Interest Guidelines In Report

April 13, 1990

In Brief: FASEB Letter urges Support Of NIH, NSF; Kansas Recruits Experts From Washington State

July 30, 1993